Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apnimed announced the closing of its upsized initial public offering of 13.8 million shares, which included the full exercise of the underwriters' overallotment option. The shares were priced at $16.00 per share, resulting in gross proceeds of $220.8 million, with trading having commenced on the Nasdaq Global Select Market on July 31.
Key figures
- Deal Value Usd
- $220.8 million
- Offering Price
- $16.00
- Shares Offered
- 13,800,000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.